Why biotech and emerging markets trades still look strong

merger

By Kevin D. Mahn, president and chief investment officer, Hennion & Walsh Asset Management

Kevin Mahn, CIO of Hennion and Walsh Asset Management, joins Yahoo Finance’s Alexis Christoforous and Pras Subramanian to discuss the investment themes he’s following this summer—from the outlook for the broader US markets, to emerging markets, to continued opportunities in biotech.

Click here to watch the video on Yahoo! Finance.
———————————————————————————————————————

Disclosure: Hennion & Walsh Asset Management currently has allocations within its managed money program and Hennion & Walsh currently has allocations within certain SmartTrust® Unit Investment Trusts (UITs) consistent with several of the portfolio management ideas for consideration cited above.